DYN
Price
$17.45
Change
+$0.41 (+2.41%)
Updated
Jan 14 closing price
Capitalization
2.87B
42 days until earnings call
Intraday BUY SELL Signals
MIRM
Price
$90.69
Change
+$0.25 (+0.28%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
4.69B
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DYN vs MIRM

Header iconDYN vs MIRM Comparison
Open Charts DYN vs MIRMBanner chart's image
Dyne Therapeutics
Price$17.45
Change+$0.41 (+2.41%)
Volume$3.63M
Capitalization2.87B
Mirum Pharmaceuticals
Price$90.69
Change+$0.25 (+0.28%)
Volume$5.05K
Capitalization4.69B
DYN vs MIRM Comparison Chart in %
DYN
Daily Signal:
Gain/Loss:
MIRM
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DYN vs. MIRM commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Hold and MIRM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (DYN: $17.45 vs. MIRM: $90.65)
Brand notoriety: DYN and MIRM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 134% vs. MIRM: 65%
Market capitalization -- DYN: $2.87B vs. MIRM: $4.69B
DYN [@Biotechnology] is valued at $2.87B. MIRM’s [@Biotechnology] market capitalization is $4.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileMIRM’s FA Score has 1 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • MIRM’s FA Score: 1 green, 4 red.
According to our system of comparison, MIRM is a better buy in the long-term than DYN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 3 TA indicator(s) are bullish while MIRM’s TA Score has 5 bullish TA indicator(s).

  • DYN’s TA Score: 3 bullish, 6 bearish.
  • MIRM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MIRM is a better buy in the short-term than DYN.

Price Growth

DYN (@Biotechnology) experienced а -10.01% price change this week, while MIRM (@Biotechnology) price change was +10.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

DYN is expected to report earnings on Feb 26, 2026.

MIRM is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MIRM($4.69B) has a higher market cap than DYN($2.87B). MIRM YTD gains are higher at: 14.496 vs. DYN (-10.787). MIRM has higher annual earnings (EBITDA): -2.23M vs. DYN (-445.29M). DYN has more cash in the bank: 792M vs. MIRM (376M). DYN has less debt than MIRM: DYN (120M) vs MIRM (319M). MIRM has higher revenues than DYN: MIRM (472M) vs DYN (0).
DYNMIRMDYN / MIRM
Capitalization2.87B4.69B61%
EBITDA-445.29M-2.23M19,933%
Gain YTD-10.78714.496-74%
P/E RatioN/AN/A-
Revenue0472M-
Total Cash792M376M211%
Total Debt120M319M38%
FUNDAMENTALS RATINGS
MIRM: Fundamental Ratings
MIRM
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
4
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DYNMIRM
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 24 days ago
85%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 10 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 2 days ago
69%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signal:
Gain/Loss:
MIRM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JUSYX19.560.13
+0.67%
JPMorgan US Small Company R5
ASIMX15.210.01
+0.07%
Alger Weatherbie Specialized Growth I
AGCVX21.38-0.04
-0.19%
American Century Global Small Cap Inv
WCMRX25.62-0.15
-0.58%
WCM Focused International Growth Inv
RSESX16.97-0.10
-0.59%
Russell Inv US Strategic Equity S

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+2.41%
RNA - DYN
59%
Loosely correlated
+0.15%
IDYA - DYN
55%
Loosely correlated
+5.53%
XNCR - DYN
55%
Loosely correlated
+3.66%
SYRE - DYN
53%
Loosely correlated
+5.17%
NRIX - DYN
50%
Loosely correlated
+0.58%
More

MIRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, MIRM has been loosely correlated with XERS. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MIRM jumps, then XERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIRM
1D Price
Change %
MIRM100%
+1.05%
XERS - MIRM
47%
Loosely correlated
-2.03%
RVMD - MIRM
43%
Loosely correlated
+2.37%
DNLI - MIRM
40%
Loosely correlated
+0.89%
TARS - MIRM
39%
Loosely correlated
+0.26%
DYN - MIRM
39%
Loosely correlated
-2.41%
More